Skip to main content

. 1987 Feb;80(2):120–121. doi: 10.1177/014107688708000221

Pulmonary eosinophilia associated with naproxen therapy.

K C Flint, N M Johnson

PMCID: PMC1290689 PMID: 3560143

120

Images in this article

Figure 1.
on p.121

Figure 2.
on p.121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Buscaglia A. J., Cowden F. E., Brill H. Pulmonary infiltrates associated with naproxen. JAMA. 1984 Jan 6;251(1):65–66. [PubMed] [Google Scholar]
Phillips H. R., Carter J. E., Okada R. D., Levine F. H., Boucher C. A., Osbakken M., Lappas D., Buckley M. J., Pohost G. M. Serial changes in left ventricular ejection fraction in the early hours after aortocoronary bypass grafting. Chest. 1983 Jan;83(1):28–34. doi: 10.1378/chest.83.1.28. [DOI] [PubMed] [Google Scholar]
Rosenow E. C., 3rd The spectrum of drug-induced pulmonary disease. Ann Intern Med. 1972 Dec;77(6):977–991. doi: 10.7326/0003-4819-77-6-977. [DOI] [PubMed] [Google Scholar]
Thurston J. G., Marks P., Trapnell D. Lung changes associated with phenylbutazone treatment. Br Med J. 1976 Dec 11;2(6049):1422–1423. doi: 10.1136/bmj.2.6049.1422. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES